Clinical trials
Terminated Phase 2 Sarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 55 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gynecologic Oncology Group | 6 |
| National Cancer Institute (NCI) | 4 |
| City of Hope Medical Center | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Hoffmann-La Roche | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| Washington University School of Medicine | 2 |
| AHS Cancer Control Alberta | 1 |
| Alaunos Therapeutics | 1 |
| Burzynski Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 55 |
| Ovarian Neoplasms | 7 |
| Breast Neoplasms | 5 |
| Osteosarcoma | 5 |
| Pancreatic Neoplasms | 5 |
| Uterine Cervical Neoplasms | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Cholangiocarcinoma | 4 |
| Colorectal Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.